AZN Stock: Price, Earnings History and SEC Filings
AstraZeneca PLC (AZN) last traded at $186.65, up 7.02% on the latest session and up 15.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.63 against an analyst estimate of $2.50, a beat of 5.2%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AZN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 27, 2026 | $2.63 | $2.50 | +5.20% |
| Mar 2026 | Apr 29, 2026 | $2.58 | $2.57 | +0.39% |
| Dec 2025 | Feb 10, 2026 | $1.06 | $2.18 | -51.38% |
| Sep 2025 | Nov 6, 2025 | $2.38 | $2.28 | +4.39% |
AZN beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AZN
Insider filing activity
AZN insiders filed 3 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
AZN news
- HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and JapanNov 2, 2026 · finance.yahoo.com
- AstraZeneca: 3 Key Takeaways for Long-Term InvestorsNov 1, 2026 · fool.com
- Haleon And 2 British AI Healthcare Stocks To WatchNov 1, 2026 · finance.yahoo.com
- AstraZeneca (AZN) Q3 2026 Earnings Call TranscriptOct 31, 2026 · fool.com
- Q3 earnings round-up: AstraZeneca, AbbVie, KenvueOct 30, 2026 · finance.yahoo.com
- AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion PotentialOct 30, 2026 · finance.yahoo.com
- COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?Oct 30, 2026 · beincrypto.com
- AstraZeneca Q3 Earnings Call HighlightsOct 30, 2026 · marketbeat.com
About AstraZeneca PLC
AstraZeneca PLC (AZN) is a US-listed public company on NYSE. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in United Kingdom. Its fiscal year ends in December.